Recordati reported EUR681.35M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Almirall EUR 602.71M 55.09M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Orion EUR 521.6M 103.9M Jun/2026
Sanofi EUR 11.95B 710M Jun/2026